Endothelium trans differentiated from wharton's jelly mesenchymal cells promote tissue regeneration: Potential role of soluble pro-angiogenic factors

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Aguilera, Valeria ^a   Briceño, Luis ^a   Contreras, Hector ^b   Lamperti, Liliana ^a   Sepúlveda, Esperanza ^a   Díaz Perez, Francisca ^a   León, Marcelo ^a   Veas, Carlos ^a   Maura, Rafael ^a   Toledo, Jorge Roberto ^a   Ndez, Paulina Ferná ^a,c   Covarrubias, Ambart ^c   Zuñiga, Felipe Andrés ^a   Radojkovic, Claudia ^a   Escudero, Carlos ^d   Aguayo, Claudio ^a,d  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b UNIVERSIDAD CATÓLICA DE LA SANTÍSIMA CONCEPCIÓN   (Chile)

^c UNIVERSIDAD SAN SEBASTIÁN   (Chile)

^d UNIVERSIDAD DEL BÍO BÍO   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ANGIOGENIC FACTOR; ANGIOPOIETIN RECEPTOR; COLLAGENASE; COLLAGENASE TYPE I; ENDOGLIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; THY 1 ANTIGEN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ADIPOCYTE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; OSTEOCYTE; PROTEIN EXPRESSION; SKIN INJURY; TISSUE REPAIR; WOUND HEALING; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CULTURE TECHNIQUE; CYTOLOGY; DISEASE MODEL; ENDOTHELIUM; INJURIES; METABOLISM; PHYSIOLOGY; SKIN;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIUM; FEMALE; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; NITRIC OXIDE; SKIN; WOUND HEALING;

EID: 84912019913     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111025     Document Type: Article

References (56)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
2. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
3. Yoon HH, Jung BY, Seo YK, Song KY, Park JK (2010) In vitro hepatic differentiation of umbilical cord-derived mesenchymal stem cell. Process Biochemistry 45: 1857-1864.
4. Yu YL, Chou RH, Chen LT, Shyu WC, Hsieh SC, et al. (2011) EZH2 regulates neuronal differentiation of mesenchymal stem cells through PIP5K1Cdependent calcium signaling. J Biol Chem 286: 9657-9667.
5. Oswald J, Boxberger S, Jorgensen B, Feldmann S, Ehninger G, et al. (2004) Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22: 377-384.
6. Harichandan A, Buhring HJ (2011) Prospective isolation of human MSC. Best Pract Res Clin Haematol 24: 25-36.
7. Tang YL, Zhao Q, Zhang YC, Cheng L, Liu M, et al. (2004) Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept 117: 3-10.
8. Tang J, Wang J, Yang J, Kong X, Zheng F, et al. (2009) Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. Eur J Cardiothorac Surg 36: 644-650.
9. Li Z, Guo J, Chang Q, Zhang A (2009) Paracrine role for mesenchymal stem cells in acute myocardial infarction. Biol Pharm Bull 32: 1343-1346.
10. Mitrano TI, Grob MS, Carrion F, Nova-Lamperti E, Luz PA, et al. (2010) Culture and characterization of mesenchymal stem cells from human gingival tissue. J Periodontol 81: 917-925.
11. Salvolini E, Lucarini G, Zizzi A, Orciani M, Di Benedetto G, et al. (2010) Human skin-derived mesenchymal stem cells as a source of VEGF and nitric oxide. Arch Dermatol Res 302: 367-374.
12. Battula VL, Bareiss PM, Treml S, Conrad S, Albert I, et al. (2007) Human placenta and bone marrow derived MSC cultured in serum-free, b-FGFcontaining medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 75: 279-291.
13. Parolini O, Alviano F, Bagnara GP, Bilic G, Buhring HJ, et al. (2008) Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26: 300-311.
14. Alviano F, Fossati V, Marchionni C, Arpinati M, Bonsi L, et al. (2007) Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol 7.
15. La Rocca G, Anzalone R, Corrao S, Magno F, Loria T, et al. (2009) Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol 131: 267-282.
16. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, et al. (2004) Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351: 2276-2285.
17. Mitchell KE, Weiss ML, Mitchell BM, Martin P, Davis D, et al. (2003) Matrix cells from Wharton's jelly form neurons and glia. Stem Cells 21: 50-60.
18. Sarugaser R, Hanoun L, Keating A, Stanford WL, Davies JE (2009) Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy. PLoS One 4: e6498.
19. Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, et al. (2006) Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91: 1017-1026.
20. Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, et al. (2007) Biology of stem cells in human umbilical cord stroma: In situ and in vitro surveys. Stem Cells 25: 319-331.
21. Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, et al. (2006) Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 24: 781-792.
22. Lund RD, Wang S, Lu B, Girman S, Holmes T, et al. (2007) Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells 25: 602-611.
23. Rachakatla RS, Marini F, Weiss ML, Tamura M, Troyer D (2007) Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors. Cancer Gene Ther 14: 828-835.
24. Conconi MT, Burra P, Di Liddo R, Calore C, Turetta M, et al. (2006) CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. Int J Mol Med 18: 1089-1096.
25. Liu Y, Wu J, Zhu Y, Han J (2012) Therapeutic application of mesenchymal stem cells in bone and joint diseases. Clin Exp Med.
26. Crisostomo PR, Wang Y, Markel TA, Wang M, Lahm T, et al. (2008) Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. American Journal of Physiology-Cell Physiology 294: C675-C682.
27. Choi M, Lee HS, Naidansaren P, Kim HK, O E., et al. (2013) Proangiogenic features of Wharton's jelly-derived mesenchymal stromal/stem cells and their ability to form functional vessels. Int J Biochem Cell Biol 45: 560-570.
28. Miranville A, Heeschen C, Sengenes C, Curat CA, Busse R, et al. (2004) Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 110: 349-355.
29. De Francesco F, Tirino V, Desiderio V, Ferraro G, D'Andrea F, et al. (2009) Human CD34(+)/CD90(+) ASCs Are Capable of Growing as Sphere Clusters, Producing High Levels of VEGF and Forming Capillaries. PLoS One 4.
30. Fu X, Li H (2009) Mesenchymal stem cells and skin wound repair and regeneration: possibilities and questions. Cell Tissue Res 335: 317-321.
31. Wang SH, Lin SJ, Chen YH, Lin FY, Shih JC, et al. (2009) Late outgrowth endothelial cells derived from Wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epitheliumderived factor. Arterioscler Thromb Vasc Biol 29: 816-822.
32. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, et al. (2004) Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109: 1543-1549.
33. Kondo K, Shintani S, Shibata R, Murakami H, Murakami R, et al. (2009) Implantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol 29: 61-66.
34. Meyer T, Pfeifroth A, Hocht B (2008) Isolation and characterisation of mesenchymal stem cells in Wharton's jelly of the human umbilical cord: potent cells for cell- based therapies in paediatric surgery? European Surgery-Acta Chirurgica Austriaca 40: 239-244.
35. Guzman-Gutierrez E, Sandoval C, Nova E, Castillo JL, Vera JC, et al. (2010) Differential expression of functional nucleoside transporters in non-differentiated and differentiated human endothelial progenitor cells. Placenta 31: 928-936.
36. Diaz-Perez F, Radojkovic C, Aguilera V, Veas C, Gonzalez M, et al. (2012) Larginine transport and nitric oxide synthesis in human endothelial progenitor cells. J Cardiovasc Pharmacol 60: 439-449.
37. Fernandez P, Jara C, Aguilera V, Caviedes L, Diaz F, et al. (2012) Adenosine A(2)A and A(3) receptors are involved in the human endothelial progenitor cells migration. J Cardiovasc Pharmacol 59: 397-404.
38. Kim SW, Zhang HZ, Guo L, Kim JM, Kim MH (2012) Amniotic mesenchymal stem cells enhance wound healing in diabetic NOD/SCID mice through high angiogenic and engraftment capabilities. PLoS One 7: e41105.
39. Wu YJ, Chen L, Scott PG, Tredget EE (2007) Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25: 2648-2659.
40. Galiano RD, Michaels J 5th, Dobryansky M, Levine JP, Gurtner GC (2004) Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen 12: 485-492.
41. Kim SW, Zhang HZ, Kim CE, Kim JM, Kim MH (2012) Amniotic mesenchymal stem cells with robust chemotactic properties are effective in the treatment of a myocardial infarction model. Int J Cardiol.
42. Panepucci RA, Siufi JLC, Silva WA, Proto-Siquiera R, Neder L, et al. (2004) Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 22: 1263-1278.
43. Chen MY, Lie PC, Li ZL, Wei X (2009) Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Exp Hematol 37: 629-640.
44. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, et al. (2004) Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22: 1330-1337.
45. Orbay H, Tobita M, Mizuno H (2012) Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications. Stem Cells Int 2012: 461718.
46. Petsa A, Gargani S, Felesakis A, Grigoriadis N, Grigoriadis I (2009) Effectiveness of protocol for the isolation of Wharton's Jelly stem cells in large-scale applications. In Vitro Cell Dev Biol Anim 45: 573-576.
47. Alaminos M, Perez-Kohler B, Garzon I, Garcia-Honduvilla N, Romer B, et al. (2010) Transdifferentiation Potentiality of Human Wharton's Jelly Stem Cells Towards Vascular Endothelial Cells. J Cell Physiol 223: 640-647.
48. Gang EJ, Jeong JA, Han S, Yan Q, Jeon CJ, et al. (2006) In vitro endothelial potential of human UC blood-derived mesenchymal stem cells. Cytotherapy 8: 215-227.
49. Oswald J, Boxberger S, Jorgensen B, Feldmann S, Ehninger G, et al. (2004) Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells. 22: 377-384.
50. Liu JW, Dunoyer-Geindre S, Serre-Beinier V, Mai G, Lambert JF, et al. (2007) Characterization of endothelial-like cells derived from human mesenchymal stem cells. J Thromb Haemost. 5: 826-834.
51. Stenderup K, Justesen J, Clausen C, Kassem M (2003) Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 33: 919-926.
52. Miao Z, Jin J, Chen L, Zhu J, Huang W, et al. (2006) Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol Int. 30: 681-687.
53. Lee PC, Salyapongse AN, Bragdon GA, Shears LL II, Watkins SC, et al. (1999) Impaired wound healing and angiogenesis in eNOS-deficient mice. Am J Physiol 277: H1600-H1608
54. Li HH, Fu XB, Ouyang YS, Cai CL, Wang J, et al. (2006) Adult bone-marrowderived mesenchymal stem cells contribute to wound healing of skin appendages. Cell Tissue Res 326: 725-736.
55. Noiseux N, Gnecchi M, Lopez-Ilasaca M, Zhang L, Solomon SD, et al. (2006) Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 14: 840-850.
56. Chen L, Tredget EE, Wu PY, Wu Y (2008) Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3: e1886.